Related Experiment Video
Updated: May 24, 2026
09:41
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
Lipid conjugated oligonucleotides: a useful strategy for delivery
Mouna Raouane1, Didier Desmaële, Giorgia Urbinati
1Laboratoire de physicochimie, Pharmacotechnie et biopharmacie, UMR CNRS 8612, Université Paris Sud 11 , Faculté de pharmacie, 5 rue J. B. Clément, 92296 Châtenay-Malabry, France.
Bioconjugate Chemistry
|March 1, 2012
Summary
Neutral lipid-oligonucleotide conjugates offer a safer alternative for delivering therapeutic nucleic acids. This approach enhances stability and cellular uptake, overcoming limitations of cationic nanoplexes for disease treatment.
Area of Science:
- Biotechnology
- Medicinal Chemistry
- Molecular Biology
Background:
- Oligonucleotides like antisense oligonucleotides and siRNA show therapeutic potential for various diseases.
- Effective delivery is crucial for clinical applications of these nucleic acid therapeutics.
- Cationic nanoplexes improve stability and cellular entry but cause protein interactions and toxicity.
Purpose of the Study:
- To review synthetic methods for conjugating lipids to oligonucleotides.
- To discuss the pharmacological efficacy of neutral lipid-oligonucleotide conjugates for enhanced delivery.
- To highlight an improved strategy for safe oligonucleotide delivery.
Main Methods:
- Chemical conjugation of hydrophobic moieties (cholesterol, squalene, fatty acids) to oligonucleotides.
- Review of synthetic strategies for creating lipid-oligonucleotide conjugates.
- Analysis of pharmacokinetic behavior and trans-membrane delivery.
Main Results:
- Neutral lipid-oligonucleotide conjugates enhance pharmacokinetic profiles.
- These conjugates improve trans-membrane delivery of oligonucleotides.
- This approach mitigates toxicity and protein interaction issues associated with cationic methods.
Conclusions:
- Neutral lipid-oligonucleotide conjugates represent a promising strategy for safe and effective oligonucleotide delivery.
- Chemical conjugation of lipids enhances the therapeutic potential of oligonucleotides.
- Further research into synthetic methods and pharmacological efficacy is warranted.
More Related Videos
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
02:50Conjugated Proteins
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:38Receptor-mediated Endocytosis
Overview